| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Katanin_con80 | 8.93e-05 | 2 | 177 | 2 | PF13925 | |
| Domain | Katanin_C-terminal | 8.93e-05 | 2 | 177 | 2 | IPR028021 | |
| Domain | LRR | 1.31e-04 | 201 | 177 | 9 | PS51450 | |
| Domain | DHR-1_domain | 1.31e-04 | 11 | 177 | 3 | IPR027007 | |
| Domain | DHR_2 | 1.31e-04 | 11 | 177 | 3 | PS51651 | |
| Domain | DHR_1 | 1.31e-04 | 11 | 177 | 3 | PS51650 | |
| Domain | DHR-2 | 1.31e-04 | 11 | 177 | 3 | PF06920 | |
| Domain | DOCK | 1.31e-04 | 11 | 177 | 3 | IPR026791 | |
| Domain | DOCK_C | 1.31e-04 | 11 | 177 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 1.31e-04 | 11 | 177 | 3 | PF14429 | |
| Domain | DHR-2 | 1.31e-04 | 11 | 177 | 3 | IPR027357 | |
| Domain | WD40_repeat_CS | 1.73e-04 | 164 | 177 | 8 | IPR019775 | |
| Domain | TECPR | 2.66e-04 | 3 | 177 | 2 | SM00706 | |
| Domain | Beta-propeller_rpt_TECPR | 2.66e-04 | 3 | 177 | 2 | IPR006624 | |
| Domain | - | FMOD LRRC30 LRCH1 ERBIN CIITA LRRC53 LRRTM2 NLRC5 LRRC36 TBCEL | 1.00e-03 | 321 | 177 | 10 | 3.80.10.10 |
| Domain | ABC_tran | 1.10e-03 | 48 | 177 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.10e-03 | 48 | 177 | 4 | PS50893 | |
| Domain | Leu-rich_rpt | 1.15e-03 | 271 | 177 | 9 | IPR001611 | |
| Domain | LRR_1 | 1.18e-03 | 219 | 177 | 8 | PF00560 | |
| Domain | WD40_repeat | 1.18e-03 | 272 | 177 | 9 | IPR001680 | |
| Domain | L_dom-like | FMOD LRRC30 LRCH1 ERBIN CIITA LRRC53 LRRTM2 NLRC5 LRRC36 TBCEL | 1.18e-03 | 328 | 177 | 10 | IPR032675 |
| Domain | ABC_TRANSPORTER_1 | 1.18e-03 | 49 | 177 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.28e-03 | 50 | 177 | 4 | IPR003439 | |
| Domain | Spectrin | 1.29e-03 | 23 | 177 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.29e-03 | 23 | 177 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.29e-03 | 23 | 177 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.29e-03 | 23 | 177 | 3 | IPR001589 | |
| Domain | DUF3398 | 1.31e-03 | 6 | 177 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 1.31e-03 | 6 | 177 | 2 | IPR021816 | |
| Domain | Liprin | 1.31e-03 | 6 | 177 | 2 | IPR029515 | |
| Domain | - | STRN3 KATNB1 BRWD3 FZR1 WDFY3 CORO7 PLXNB1 PLXNB3 TBL1X DCAF12 | 1.32e-03 | 333 | 177 | 10 | 2.130.10.10 |
| Domain | WD_REPEATS_1 | 1.37e-03 | 278 | 177 | 9 | PS00678 | |
| Domain | WD40/YVTN_repeat-like_dom | STRN3 KATNB1 BRWD3 FZR1 WDFY3 CORO7 PLXNB1 PLXNB3 TBL1X DCAF12 | 1.38e-03 | 335 | 177 | 10 | IPR015943 |
| Domain | WD_REPEATS_2 | 1.40e-03 | 279 | 177 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.40e-03 | 279 | 177 | 9 | PS50294 | |
| Pubmed | 1.34e-06 | 103 | 184 | 7 | 10574462 | ||
| Pubmed | DOCK3 ATRN ABHD14A EPRS1 COG2 PPFIBP1 SYNE1 SPTBN1 CEP290 MDH1 NSUN2 BRWD3 SACS KCNJ6 ZNF197 MACF1 ENPP5 MCRS1 WDFY3 HERC2 PLXNB3 SEZ6L | 1.38e-06 | 1285 | 184 | 22 | 35914814 | |
| Pubmed | 1.45e-06 | 5 | 184 | 3 | 12183458 | ||
| Pubmed | RAPGEF5 SYNE1 ARHGEF12 FAM91A1 ERBIN MCM3AP LRRTM2 DOCK7 MACF1 VPS13B PLXNB3 SEZ6L | 2.01e-06 | 407 | 184 | 12 | 12693553 | |
| Pubmed | SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity. | TRAF3 SLC36A1 GNE CCDC30 SWT1 UNC13D PKD1L2 PIR FOXI3 CRB1 GJA3 SENP1 KATNBL1 NTAN1 TIMP1 FAM222B LRRTM2 | 8.25e-06 | 915 | 184 | 17 | 32393512 |
| Pubmed | TPR STRN3 TRAF3 ABR DOCK11 SYNE1 SPTBN1 ARHGEF12 GRM3 ERBIN SENP1 DOCK7 MACF1 WDFY3 HERC2 TBL1X TPD52L2 | 1.59e-05 | 963 | 184 | 17 | 28671696 | |
| Pubmed | 2.33e-05 | 11 | 184 | 3 | 24337748 | ||
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 2.33e-05 | 11 | 184 | 3 | 39256359 | |
| Pubmed | Repressive histone methylation regulates cardiac myocyte cell cycle exit. | 2.78e-05 | 2 | 184 | 2 | 29800554 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19837407 | ||
| Pubmed | Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein. | 2.78e-05 | 2 | 184 | 2 | 22802462 | |
| Pubmed | NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity. | 2.78e-05 | 2 | 184 | 2 | 37108368 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 16647293 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 34370374 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22302708 | ||
| Pubmed | Opposing Roles of FANCJ and HLTF Protect Forks and Restrain Replication during Stress. | 2.78e-05 | 2 | 184 | 2 | 30232006 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22119253 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 21840001 | ||
| Pubmed | Cutting edge: impaired MHC class I expression in mice deficient for Nlrc5/class I transactivator. | 2.78e-05 | 2 | 184 | 2 | 22711889 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 25197626 | ||
| Pubmed | Kdm4d mutant mice show impaired sperm motility and subfertility. | 2.78e-05 | 2 | 184 | 2 | 39034148 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 25281535 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 32094404 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 30472235 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22672264 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 21859969 | ||
| Pubmed | NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. | 2.78e-05 | 2 | 184 | 2 | 20639463 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22178419 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 15102890 | ||
| Pubmed | The polyphenol PGG enhances expression of SR-BI and ABCA1 in J774 and THP-1 macrophages. | 2.78e-05 | 2 | 184 | 2 | 26322417 | |
| Pubmed | NLRC5: a key regulator of MHC class I-dependent immune responses. | 2.78e-05 | 2 | 184 | 2 | 23175229 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 26165328 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 35027670 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 25417163 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22645137 | ||
| Pubmed | Mice doubly-deficient in the Arf GAPs SMAP1 and SMAP2 exhibit embryonic lethality. | 2.78e-05 | 2 | 184 | 2 | 26296315 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 16410457 | ||
| Pubmed | Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. | 3.09e-05 | 12 | 184 | 3 | 12123608 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 3.09e-05 | 12 | 184 | 3 | 9624153 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR EPRS1 SETX GNE SPTBN1 AGPS LYAR ADAR NSUN2 ERBIN IGHG1 MCM3AP A2ML1 LTN1 HLTF PKP2 MACF1 WDFY3 HERC2 CORO7 | 3.57e-05 | 1353 | 184 | 20 | 29467282 |
| Pubmed | 3.77e-05 | 234 | 184 | 8 | 36243803 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATRN ABR DHRS3 PPFIA2 TMEM63B ADGRG1 SLC30A4 ERBIN GALNT18 BRWD3 SENP1 PKP3 SCARB1 NLRC5 MACF1 ENPP5 PLCB4 CFAP69 VPS13B EVI5L TBL1X | 4.45e-05 | 1489 | 184 | 21 | 28611215 |
| Pubmed | 5.08e-05 | 14 | 184 | 3 | 1912584 | ||
| Pubmed | 5.08e-05 | 14 | 184 | 3 | 12432077 | ||
| Pubmed | EPRS1 ABR NUP85 BAG5 CEP290 KATNB1 MED14 AGPS ADAR F5 COG8 MED15 PTPRC CD37 HLTF HERC2 CORO7 IL2RG | 5.27e-05 | 1168 | 184 | 18 | 19946888 | |
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 5.70e-05 | 77 | 184 | 5 | 24927568 | |
| Pubmed | TPR EPRS1 SETX RAPGEF5 SPTBN1 FAM91A1 UNC13D ANKRD50 UBOX5 ERBIN SLFN12L PTPRC LTN1 MACF1 DOT1L VPS13B PLXNB1 | 6.94e-05 | 1084 | 184 | 17 | 11544199 | |
| Pubmed | SMAP1 SETX CCDC30 PPFIBP1 FAM91A1 AGPS ANKRD50 PKHD1L1 ERBIN CRB1 DOCK7 PKP2 SMAP2 TPD52L2 | 7.36e-05 | 777 | 184 | 14 | 35844135 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 26255968 | ||
| Pubmed | Cellular physiology of cholesterol efflux in vascular endothelial cells. | 8.32e-05 | 3 | 184 | 2 | 15492319 | |
| Pubmed | Dynamic regulation of CD45 lateral mobility by the spectrin-ankyrin cytoskeleton of T cells. | 8.32e-05 | 3 | 184 | 2 | 20164196 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 16192274 | ||
| Pubmed | Thrombosis Related ABO, F5, MTHFR, and FGG Gene Polymorphisms in Morbidly Obese Patients. | 8.32e-05 | 3 | 184 | 2 | 27999448 | |
| Pubmed | Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors. | 8.32e-05 | 3 | 184 | 2 | 12220504 | |
| Pubmed | Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers. | 8.32e-05 | 3 | 184 | 2 | 21947748 | |
| Pubmed | Cellular cholesterol transport proteins in diabetic nephropathy. | 8.32e-05 | 3 | 184 | 2 | 25181357 | |
| Pubmed | Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. | 8.32e-05 | 3 | 184 | 2 | 17657311 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 12196628 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 12917427 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 17008588 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 27377933 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 20348106 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 29748333 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 19515723 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 30694837 | ||
| Pubmed | Whole exome sequencing of ENU-induced thrombosis modifier mutations in the mouse. | 8.32e-05 | 3 | 184 | 2 | 30188893 | |
| Pubmed | Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects. | 8.32e-05 | 3 | 184 | 2 | 18057374 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 21855798 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 21555854 | ||
| Pubmed | Plakophilin-1 localizes to the nucleus and interacts with single-stranded DNA. | 8.32e-05 | 3 | 184 | 2 | 20613778 | |
| Pubmed | Fibrinogen γ' increases the sensitivity to activated protein C in normal and factor V Leiden plasma. | 8.32e-05 | 3 | 184 | 2 | 24951429 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 22614118 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 34010296 | ||
| Pubmed | ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. | 8.32e-05 | 3 | 184 | 2 | 19805087 | |
| Pubmed | Plakophilin 3--a novel cell-type-specific desmosomal plaque protein. | 8.32e-05 | 3 | 184 | 2 | 10374265 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 25972099 | ||
| Pubmed | Oocytes mount a noncanonical DNA damage response involving APC-Cdh1-mediated proteolysis. | 8.32e-05 | 3 | 184 | 2 | 32328643 | |
| Pubmed | NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module. | 8.32e-05 | 3 | 184 | 2 | 25811463 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 17399905 | ||
| Pubmed | ABCA1, ABCG1 and SR-BI: hormonal regulation in primary rat hepatocytes and human cell lines. | 8.32e-05 | 3 | 184 | 2 | 17241464 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 25852127 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 17906976 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 21289254 | ||
| Pubmed | Protein tyrosine phosphatase-σ regulates hematopoietic stem cell-repopulating capacity. | 8.32e-05 | 3 | 184 | 2 | 25415437 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 18640393 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 38905308 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 21293030 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 18355969 | ||
| Pubmed | The roles of different pathways in the release of cholesterol from macrophages. | 8.32e-05 | 3 | 184 | 2 | 17761631 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 20018934 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 29853565 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 18450749 | ||
| Pubmed | Reduced thrombin generation increases host susceptibility to group A streptococcal infection. | 8.32e-05 | 3 | 184 | 2 | 19056689 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 21071707 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 29540530 | ||
| Pubmed | Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI. | 8.32e-05 | 3 | 184 | 2 | 22190590 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 24908654 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 22383685 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 35675330 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 20606166 | ||
| Coexpression | GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN | 1.12e-05 | 199 | 182 | 9 | M7099 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_65_81Y0_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_UP | 1.13e-05 | 7 | 182 | 3 | M41164 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | ABCA1 GNE DOCK11 RAPGEF5 PPFIBP1 SPTBN1 LRCH1 GALNT18 KATNBL1 PTPRC TIE1 TIMP1 SACS SCARB1 MACF1 CLDN5 PLCB4 ARHGAP27 AMMECR1 ST8SIA4 SMAP2 IL2RG | 9.64e-07 | 831 | 171 | 22 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | ABCA1 DOCK11 RAPGEF5 LRCH1 GALNT18 KATNBL1 PTPRC TIE1 SACS SCARB1 CLDN5 PLCB4 ARHGAP27 AMMECR1 ST8SIA4 SMAP2 IL2RG | 3.80e-06 | 570 | 171 | 17 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | ABCA1 GNE DOCK11 RAPGEF5 LRCH1 CPED1 GALNT18 KATNBL1 TIE1 TIMP1 SACS SCARB1 LRRTM2 CLDN5 PLCB4 ARHGAP27 AMMECR1 ST8SIA4 SMAP2 IL2RG | 1.68e-05 | 847 | 171 | 20 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | ATRN ABCA1 DHRS3 GNE RAPGEF5 PPFIBP1 SYNE1 SPTBN1 ADGRG1 LRCH1 CPED1 GALNT18 SLFN12L TIE1 LTN1 MACF1 ENPP5 PLCB4 ST8SIA4 IL2RG | 1.77e-05 | 850 | 171 | 20 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | ABCA1 DOCK11 RAPGEF5 CPED1 PTPRC TIE1 TIMP1 SCARB1 CLDN5 PLCB4 AMMECR1 ST8SIA4 IL2RG | 4.79e-05 | 430 | 171 | 13 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | ABCA1 DOCK11 RAPGEF5 PTPRC TIE1 CLDN5 PLCB4 AMMECR1 ST8SIA4 IL2RG | 1.00e-04 | 282 | 171 | 10 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k4_500 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.29e-09 | 186 | 182 | 10 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SETX DHRS3 RAPGEF5 SPTBN1 ARHGEF12 ADGRG1 GALNT18 TIE1 SCARB1 ARHGAP27 | 1.06e-08 | 200 | 182 | 10 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.07e-08 | 177 | 182 | 9 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | (10)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | COL19A1 RUBCNL PKHD1L1 TSPAN33 C1orf220 CIITA GLDC IGHG1 CD37 | 8.50e-08 | 188 | 182 | 9 | fa1346902021c3a6557555ada0fd37b29cf9d5ec |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.50e-08 | 188 | 182 | 9 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | (1)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | COL19A1 RUBCNL PKHD1L1 TSPAN33 C1orf220 CIITA GLDC IGHG1 CD37 | 8.50e-08 | 188 | 182 | 9 | 642a334f2d5b6dc9df4a9fa0558833bd37bd3c58 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.90e-08 | 189 | 182 | 9 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.74e-08 | 191 | 182 | 9 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RAPGEF5 ARHGEF12 ADGRG1 GALNT18 TIE1 NLRC5 CLDN5 PLCB4 LRRC36 | 1.02e-07 | 192 | 182 | 9 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd |
| ToppCell | Control-Endothelial-Lymphatic|Control / Disease state, Lineage and Cell class | FMOD RAPGEF5 PPFIBP1 SPTBN1 PKHD1L1 GALNT18 TIE1 CLDN5 PLCB4 | 1.06e-07 | 193 | 182 | 9 | 64d19be73e5432d491436a01da5de5c926b615a9 |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PPFIBP1 SPTBN1 PKHD1L1 GALNT18 NTAN1 TIE1 TIMP1 IPCEF1 CLDN5 | 1.11e-07 | 194 | 182 | 9 | 937ee85ffd50869b60f0f6e91017ab77e8b24c0b |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | RAPGEF5 PPFIBP1 SPTBN1 ARHGEF12 PKHD1L1 GALNT18 TIE1 CLDN5 PLCB4 | 1.11e-07 | 194 | 182 | 9 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | ABCA13 SYNE1 SPTBN1 ARHGEF12 GALNT18 MACF1 PLCB4 CFAP69 WWC1 | 1.21e-07 | 196 | 182 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | ABCA13 SYNE1 SPTBN1 ARHGEF12 GALNT18 MACF1 PLCB4 CFAP69 WWC1 | 1.21e-07 | 196 | 182 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-07 | 198 | 182 | 9 | 99d6a64f3410dae3019161feef20a8f06081a24b | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-07 | 198 | 182 | 9 | 863765ccc0205dc28864dae85af339c283194c96 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | RAPGEF5 PPFIBP1 SPTBN1 ARHGEF12 ADGRG1 ADAR GALNT18 TIE1 MACF1 | 1.44e-07 | 200 | 182 | 9 | 2d07237022b409c4fac6fcf99b68c8affb3007cd |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SETX RAPGEF5 SPTBN1 ARHGEF12 ANKRD50 ADAR GALNT18 TIE1 MACF1 | 1.44e-07 | 200 | 182 | 9 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.09e-07 | 159 | 182 | 8 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.57e-07 | 162 | 182 | 8 | 19395bdb282b4a2d88cd33191af12c24a88c3d16 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-Naive_B_cells|blood / Manually curated celltypes from each tissue | 5.63e-07 | 172 | 182 | 8 | f16f90d17feac1ee52fd513907b28456865fd31d | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-B_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-07 | 178 | 182 | 8 | 5b6f7e8a930c239db1f31edfb61b2b9228d28663 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-07 | 181 | 182 | 8 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.27e-07 | 181 | 182 | 8 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.62e-07 | 182 | 182 | 8 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-07 | 182 | 182 | 8 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.62e-07 | 182 | 182 | 8 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.99e-07 | 183 | 182 | 8 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Memory_B_cells|bone_marrow / Manually curated celltypes from each tissue | 9.36e-07 | 184 | 182 | 8 | ffc9eec123de34a4f17ed27fe4f0a1b3cb84697f | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.36e-07 | 184 | 182 | 8 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.75e-07 | 185 | 182 | 8 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-07 | 185 | 182 | 8 | d9be5853acdda7b1ac819cf50c7940d1d2362d15 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 9.75e-07 | 185 | 182 | 8 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-06 | 186 | 182 | 8 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 1.02e-06 | 186 | 182 | 8 | 5624b1fc7eab9f505588fcc86a24d14f8bcbfef7 | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 187 | 182 | 8 | 51336037dfd4bbe9fe9ce1e5b6b92d037156690c | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 1.06e-06 | 187 | 182 | 8 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 187 | 182 | 8 | 43e35ec995afd8780893de42ac4ee466794991d7 | |
| ToppCell | facs-SCAT-Fat-24m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 187 | 182 | 8 | 8ca9481d661626f6f0e1b61eb142b051192a9208 | |
| ToppCell | (0)_NK_CD160pos|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.15e-06 | 189 | 182 | 8 | 713991025bb92d38cb0507ff01fd91b48c8af45a | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-06 | 189 | 182 | 8 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue | 1.19e-06 | 190 | 182 | 8 | 3d45d5011305f13634013d9eeb98f235517dd54e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-06 | 190 | 182 | 8 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 190 | 182 | 8 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.19e-06 | 190 | 182 | 8 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 190 | 182 | 8 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | IPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.19e-06 | 190 | 182 | 8 | ac029e73da5995221c9b9af551d85e4b835e21d6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 191 | 182 | 8 | baa70781633a3fe5bf987f9d8dff3884f5167e7f | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.24e-06 | 191 | 182 | 8 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-06 | 191 | 182 | 8 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 1.24e-06 | 191 | 182 | 8 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | B_cells-Memory_B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.29e-06 | 192 | 182 | 8 | eef591095921ede098f41a2b81897b18915bb753 | |
| ToppCell | (100)_CD19+_Naive_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.29e-06 | 192 | 182 | 8 | ae7e6ed7b6cc1dd45bc0547783515beecad7792a | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.34e-06 | 193 | 182 | 8 | d7750a7575ef257963b7f1c64fa67c52dbff797b | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 1.34e-06 | 193 | 182 | 8 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.34e-06 | 193 | 182 | 8 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.34e-06 | 193 | 182 | 8 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-06 | 193 | 182 | 8 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.34e-06 | 193 | 182 | 8 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | COPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class | 1.34e-06 | 193 | 182 | 8 | 18bcf08068a236c4575c7a07181ac893dfdcbeeb | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.34e-06 | 193 | 182 | 8 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 1.34e-06 | 193 | 182 | 8 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.34e-06 | 193 | 182 | 8 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 1.39e-06 | 194 | 182 | 8 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 1.39e-06 | 194 | 182 | 8 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.45e-06 | 195 | 182 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.45e-06 | 195 | 182 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-06 | 195 | 182 | 8 | 590c0dc0db4dc62879645ed7f61292ff97d2c7d5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-06 | 195 | 182 | 8 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.50e-06 | 196 | 182 | 8 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.50e-06 | 196 | 182 | 8 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | severe_influenza-CD8+_Tem|World / disease group, cell group and cell class (v2) | 1.50e-06 | 196 | 182 | 8 | 40fb254abcab2e65affc5d6037e71893a031d264 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 1.50e-06 | 196 | 182 | 8 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.50e-06 | 196 | 182 | 8 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.56e-06 | 197 | 182 | 8 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-06 | 197 | 182 | 8 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.56e-06 | 197 | 182 | 8 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-06 | 197 | 182 | 8 | 407231542fa1ffd540dcb61435c0575e71f59725 | |
| ToppCell | T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.62e-06 | 198 | 182 | 8 | 1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-06 | 198 | 182 | 8 | 5d42f4fda2081ea3e9f62a00e7eea702e0d0be7d | |
| ToppCell | 5'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-06 | 198 | 182 | 8 | 90e85fe7a0ab376a41666dfff6c0e95b7f1c9475 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.62e-06 | 198 | 182 | 8 | c54da37aa11f82a68e591d563b3db9121d6b498f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 198 | 182 | 8 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.62e-06 | 198 | 182 | 8 | 90023468f3498548a92d75928f476b4157bde813 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-06 | 198 | 182 | 8 | 824461cf44098440ba8bc0df96735423ac65bda1 | |
| ToppCell | Bronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-06 | 199 | 182 | 8 | 36a230b80096455df26c2e2c8c05fd6b231508c5 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.68e-06 | 199 | 182 | 8 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.68e-06 | 199 | 182 | 8 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|COVID-19_Severe / disease group, cell group and cell class | 1.68e-06 | 199 | 182 | 8 | a16b961996291bd5958c3851b7fdd7b45c53e19b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.75e-06 | 200 | 182 | 8 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 200 | 182 | 8 | 48131c7c9444af84afb23184382d82e850acb445 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.75e-06 | 200 | 182 | 8 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.75e-06 | 200 | 182 | 8 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| Disease | Agouti-related protein measurement | 2.02e-05 | 27 | 178 | 4 | EFO_0008016 | |
| Disease | carotene diol (2) measurement | 1.08e-04 | 3 | 178 | 2 | EFO_0800171 | |
| Disease | carotene diol (1) measurement | 1.08e-04 | 3 | 178 | 2 | EFO_0800170 | |
| Disease | paired immunoglobulin-like type 2 receptor alpha measurement | 1.08e-04 | 3 | 178 | 2 | EFO_0801866 | |
| Disease | systemic lupus erythematosus | TRAF3 ZFP90 TCP11 TSPAN33 AGXT2 PTPRC CIITA GLDC IPCEF1 CD37 ARHGAP27 DOT1L IKBKB ST8SIA4 HSP90AA4P | 1.09e-04 | 799 | 178 | 15 | MONDO_0007915 |
| Disease | apolipoprotein A 1 measurement | ABCA1 TRAF3 NEIL2 UNC13D ADAR FZR1 C1orf220 NTAN1 SCARB1 DOCK7 NLRC5 MACF1 FOXK1 CDH17 SORL1 | 2.07e-04 | 848 | 178 | 15 | EFO_0004614 |
| Disease | Colorectal Carcinoma | ABCA1 ZNF560 ABCA13 SYNE1 F5 OSBP FOXL2 SACS MCM3AP MCRS1 DSEL ST8SIA4 SORL1 | 3.58e-04 | 702 | 178 | 13 | C0009402 |
| Disease | heart rate | 4.52e-04 | 225 | 178 | 7 | EFO_0004326 | |
| Disease | free cholesterol in HDL measurement | 5.11e-04 | 61 | 178 | 4 | EFO_0022264 | |
| Disease | antihyperlipidemic drug use measurement | 6.78e-04 | 115 | 178 | 5 | EFO_0803367 | |
| Disease | total lipids in very large HDL measurement | 6.89e-04 | 66 | 178 | 4 | EFO_0022312 | |
| Disease | cholesterol in very large HDL measurement | 8.15e-04 | 69 | 178 | 4 | EFO_0022229 | |
| Disease | cutaneous melanoma | 8.54e-04 | 121 | 178 | 5 | EFO_0000389 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 8.57e-04 | 31 | 178 | 3 | EFO_0022249 | |
| Disease | retinal degeneration (implicated_via_orthology) | 1.03e-03 | 33 | 178 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | polyunsaturated fatty acid measurement | 1.22e-03 | 131 | 178 | 5 | EFO_0010733 | |
| Disease | free cholesterol in small HDL measurement | 1.23e-03 | 35 | 178 | 3 | EFO_0022270 | |
| Disease | Asthma, Occupational | 1.58e-03 | 10 | 178 | 2 | C0264423 | |
| Disease | Hypercholesterolemia | 1.68e-03 | 39 | 178 | 3 | C0020443 | |
| Disease | Malignant neoplasm of breast | BRIP1 COL19A1 SYNE1 MED14 RFX2 ADAR PPP1R3A PTPRC NLRC5 MACF1 HERC2 IKBKB VPS13B PLXNB1 SORL1 | 2.27e-03 | 1074 | 178 | 15 | C0006142 |
| Disease | candidiasis (implicated_via_orthology) | 2.38e-03 | 44 | 178 | 3 | DOID:1508 (implicated_via_orthology) | |
| Disease | coronary artery disease | ABCA1 CCDC30 ARHGEF12 NOX3 UNC13D DCLRE1B ANKRD50 SENP1 C1orf220 SCARB1 ST8SIA4 CORO7 ABCC10 CDH17 SEZ6L TBL1X | 2.46e-03 | 1194 | 178 | 16 | EFO_0001645 |
| Disease | white matter microstructure measurement | 2.64e-03 | 390 | 178 | 8 | EFO_0005674 | |
| Disease | mean fractional anisotropy measurement | 2.66e-03 | 95 | 178 | 4 | EFO_0008399 | |
| Disease | velocity of sound measurement | 2.70e-03 | 13 | 178 | 2 | EFO_0005654 | |
| Disease | homostachydrine measurement | 2.70e-03 | 13 | 178 | 2 | EFO_0021164 | |
| Disease | Leber congenital amaurosis (implicated_via_orthology) | 2.70e-03 | 13 | 178 | 2 | DOID:14791 (implicated_via_orthology) | |
| Disease | phosphoglycerides measurement | 3.06e-03 | 48 | 178 | 3 | EFO_0022291 | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 3.08e-03 | 162 | 178 | 5 | EFO_0004612, EFO_0007878 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 3.12e-03 | 315 | 178 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | Fanconi anemia | 3.14e-03 | 14 | 178 | 2 | cv:C0015625 | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 3.14e-03 | 14 | 178 | 2 | DOID:627 (is_implicated_in) | |
| Disease | rostral middle frontal gyrus volume measurement | 3.14e-03 | 14 | 178 | 2 | EFO_0010328 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.39e-03 | 239 | 178 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 3.60e-03 | 168 | 178 | 5 | EFO_0004329, EFO_0004612 | |
| Disease | Hepatitis C | 3.61e-03 | 15 | 178 | 2 | C0019196 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 3.61e-03 | 15 | 178 | 2 | C2930967 | |
| Disease | disease recurrence, colon carcinoma | 3.63e-03 | 51 | 178 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | Retinitis Pigmentosa | 3.68e-03 | 104 | 178 | 4 | C0035334 | |
| Disease | high density lipoprotein particle size measurement | 3.78e-03 | 170 | 178 | 5 | EFO_0008592 | |
| Disease | lipoprotein measurement | 3.81e-03 | 105 | 178 | 4 | EFO_0004732 | |
| Disease | alcohol use disorder (is_implicated_in) | 4.11e-03 | 16 | 178 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | Leber congenital amaurosis | 4.11e-03 | 16 | 178 | 2 | cv:C0339527 | |
| Disease | lower face morphology measurement | 4.36e-03 | 109 | 178 | 4 | EFO_0010948 | |
| Disease | phospholipids in medium HDL measurement | 4.50e-03 | 55 | 178 | 3 | EFO_0022295 | |
| Disease | urate measurement, bone density | 4.52e-03 | 619 | 178 | 10 | EFO_0003923, EFO_0004531 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 4.64e-03 | 17 | 178 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism | 4.64e-03 | 17 | 178 | 2 | EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140 | |
| Disease | bone fracture | 4.79e-03 | 112 | 178 | 4 | EFO_0003931 | |
| Disease | cholesteryl ester measurement | 4.82e-03 | 257 | 178 | 6 | EFO_0010351 | |
| Disease | Bone marrow hypocellularity | 5.20e-03 | 18 | 178 | 2 | C1855710 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 5.20e-03 | 18 | 178 | 2 | OBA_2045065 | |
| Disease | total lipids in medium HDL measurement | 5.22e-03 | 58 | 178 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 5.22e-03 | 58 | 178 | 3 | EFO_0022267 | |
| Disease | cholesterol in medium HDL measurement | 5.48e-03 | 59 | 178 | 3 | EFO_0021903 | |
| Disease | triglycerides to total lipids in large HDL percentage | 5.74e-03 | 60 | 178 | 3 | EFO_0022330 | |
| Disease | Cholecystitis | 5.78e-03 | 19 | 178 | 2 | HP_0001082 | |
| Disease | anorectal malformation | 5.78e-03 | 19 | 178 | 2 | MONDO_0019938 | |
| Disease | Omenn Syndrome | 5.78e-03 | 19 | 178 | 2 | C2700553 | |
| Disease | HMG CoA reductase inhibitor use measurement | 5.90e-03 | 189 | 178 | 5 | EFO_0009932 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 5.96e-03 | 447 | 178 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | phospholipids in HDL measurement | 6.01e-03 | 61 | 178 | 3 | EFO_0022293 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IQLDPQTVETKNWHT | 596 | Q12979 | |
| VAQKQLGRLWHTSTV | 126 | Q9BYV1 | |
| KLQLQELSDTWQAHL | 526 | Q96CN4 | |
| IGSWKNITVLFLHSN | 341 | Q96RT1 | |
| SVLTWNVTKAGHVAQ | 436 | Q8IZF5 | |
| DINSHTGEIWLKNSI | 621 | Q96JP9 | |
| HKAVWNVLGNLSEIQ | 366 | Q9UL15 | |
| NNLNCTWIIETSHGK | 946 | Q7Z408 | |
| GVHFLTQSEVQNLWK | 901 | A4D0V7 | |
| WESLQQHGETKLLQA | 896 | P33076 | |
| LVLHWQNGTKAIFDS | 291 | Q15327 | |
| HLAQPGTLKEVWSQL | 371 | O95264 | |
| LKVGHWAETLSLDVN | 481 | Q14832 | |
| NKGWHAISSFLNVIN | 1596 | O95477 | |
| WNITAVKLGHINFTI | 856 | A8K2U0 | |
| DILNISSLWTNHLKS | 766 | Q86UQ4 | |
| QNIWLHLITLGKEFQ | 1541 | Q86UQ4 | |
| LLKVWNSITGQLLHT | 446 | Q6RI45 | |
| LQSAAWQGHVKVVQL | 1016 | Q9ULJ7 | |
| QKQGIWSEIHFILTN | 516 | A6NK59 | |
| AIDSIHQLWKGTTQP | 81 | Q8TEK3 | |
| LAKLHVNGKSTWTNQ | 471 | Q05D60 | |
| HLQVSKQWIQALEVG | 61 | Q9H816 | |
| QLGLTEKSVQEDWQH | 1266 | Q9NZN5 | |
| VSNFSKQLLDSIWHQ | 486 | Q9H714 | |
| WLNHNTIKNIEGLQT | 126 | Q6ZRR7 | |
| WTLLSLVLSQHVKND | 771 | O94822 | |
| LKNTWLSGVNLLVHQ | 871 | O94822 | |
| LHLSALWLKNQVQAS | 896 | O94822 | |
| KWTTLNSLQLHGLQL | 286 | Q08J23 | |
| NSHTWEQLGTLQLLS | 106 | Q9BUJ0 | |
| ENSSAVLLQWHEKAL | 121 | Q9BPX5 | |
| LSHWISQLKAENSSQ | 906 | Q5T3U5 | |
| LLWIALHGNQITSDK | 131 | Q06828 | |
| KAGWQNSIRHNLSLN | 186 | A8MTJ6 | |
| QLSGLWEQENHLTLV | 271 | Q9H079 | |
| LHTLFLQWNKISNLT | 231 | O43300 | |
| LETLQKVTINGSTWH | 2791 | Q5T1H1 | |
| SLQSLWLQDTQVHGK | 36 | Q969S2 | |
| GQVWHSIQTLKEDCN | 431 | O14920 | |
| KTHQGNLQTLLLHWL | 26 | Q8N8D9 | |
| WHSQLTQEISVLKEL | 1001 | Q8IX03 | |
| NSGKHWIASGQTLLQ | 666 | Q86W92 | |
| RTLHSLTQWNGLINK | 2151 | O95714 | |
| LSWSVSSKLNQHAEL | 381 | P48051 | |
| TWHKDGQALTRLENN | 3536 | Q8NDA2 | |
| QAVWHLTNSSEKGID | 1046 | A6NM62 | |
| QSAIRVQHWKLLTGN | 446 | Q5FYB0 | |
| DLDKNTWSILHTQGA | 481 | O75882 | |
| VINLDQLHSSWKNVP | 301 | Q658Y4 | |
| GSTKVLQAVQWLVSH | 1546 | O60318 | |
| WKLQEIVAHASNVSS | 11 | Q9BVA0 | |
| KQNLVSGWLSDLQTH | 41 | P06126 | |
| LKLQGHQDQIFSLAW | 631 | P57737 | |
| NDVKNVIIWGNHSST | 176 | P40925 | |
| GISDQDTIHIWKTNS | 1966 | O43157 | |
| EDLTSVTQNHWKRLN | 1591 | Q9ULL4 | |
| QLLELVDKHWNGSGS | 531 | Q1X8D7 | |
| GNTQTLTELELKWQH | 246 | Q9BW27 | |
| KLWNTLNLIITSDHG | 226 | Q9UJA9 | |
| LSHTQMNTGLQKWDT | 16 | Q8WU58 | |
| AHGLQLWVNLRSSEK | 111 | O00625 | |
| KGWQNSIRHNLSLNE | 96 | P58012 | |
| ESAIFHGWVLQKVSQ | 311 | Q96MW5 | |
| KHSVTALLNTWAQSV | 766 | Q96RN5 | |
| DENTKQWNLGHLGTI | 146 | Q6B0I6 | |
| TKQWNLGHLGTILDL | 146 | B2RXH2 | |
| QSVALLEQKWHVVSS | 2541 | O94854 | |
| TWAKQHQQRLETALS | 2991 | O94854 | |
| VHWQTEGIISSSKDQ | 431 | Q9Y2L9 | |
| TVHNIIVGKLWIDQS | 581 | P22059 | |
| LQLNKLHVQGSDTWQ | 56 | Q86WI3 | |
| IQDEGTQWFLQKHIS | 66 | Q7Z442 | |
| KGSSISIQWNSIHQK | 816 | O60244 | |
| QHKQSWNVLESQGKS | 651 | Q16821 | |
| EANHIIKNSQVWVGT | 636 | Q9BX63 | |
| LLLWANGVLNESKHQ | 211 | Q7RTM1 | |
| EFWLGNEKIHLISTQ | 251 | P02679 | |
| GGNDNKLLVWNHSSL | 331 | Q9UM11 | |
| VLSLWLTENSKQHNI | 146 | Q9NQC8 | |
| KSHEAIQALNTWEVN | 421 | Q9Y2F5 | |
| WLNKLGSAVIHQEST | 131 | Q8WWN9 | |
| ALGTNLQVQFWHKTV | 246 | O00115 | |
| VIKQGWLHKANVNST | 166 | Q5JSL3 | |
| SEWSQIHENIIRKSS | 351 | Q8IZD9 | |
| LQEAFSKIVHQSTGW | 1821 | Q96N67 | |
| KIAVSTQAWNQHSGV | 196 | P55265 | |
| LHSTKLIQEWNSVDL | 486 | Q9Y223 | |
| LHTIEQAWEQETKLG | 1021 | O15078 | |
| LFDRQWHKLGISIQS | 166 | Q14993 | |
| WHKLGISIQSQVISL | 171 | Q14993 | |
| LGTLNKVFASQWLNH | 86 | Q5T6F0 | |
| ANLKSGNNLLWLHTS | 196 | Q5T3F8 | |
| GQSKLNSWIQGVLSH | 106 | Q00597 | |
| LVLQKCSGQHWSITN | 586 | Q6P9A2 | |
| EQLIHSNKWTISSIQ | 576 | Q5VVM6 | |
| DKGWQNSIRHNLSLN | 346 | P85037 | |
| TVWKLQPTAGLQDLH | 236 | Q9Y653 | |
| QELHKWQVLVDSITG | 321 | Q96EZ8 | |
| TLHKLSESQLELNWN | 161 | P31785 | |
| LASTQSELTLSQKHW | 171 | P01854 | |
| SLKVHNESILDQVWN | 121 | Q9NX58 | |
| AKTHLVVLWASQANT | 276 | P22680 | |
| VSVLTVLHQDWLNGK | 186 | P01857 | |
| VLSNWIDQFGQHIKS | 486 | Q14527 | |
| ANSTIVQRLWKHGLE | 211 | Q58FG1 | |
| IQQWLEGTLSESTHK | 631 | Q14746 | |
| AHTLGSPLTLKQVQW | 1696 | A6NE01 | |
| IKIDWNHITLENISS | 646 | P82279 | |
| GHILNSWKEQVESKT | 71 | Q9H4G1 | |
| LENAQEHSTVIGKVW | 11 | Q9Y6H8 | |
| SLQNDWEVSKINGTH | 711 | Q12864 | |
| QHQQLLASEWATKDG | 46 | Q5T0J3 | |
| WVLKVLQHLSTSEVN | 216 | A5D8W1 | |
| WSKETLQNTVDILLH | 3616 | Q9NZJ4 | |
| GWLQSLVQDTKLHLQ | 921 | Q8IZU8 | |
| AQGLQKWLHNNLISI | 231 | P11049 | |
| LKSQHINTLGQFWTT | 141 | O75911 | |
| FLWGLSEVQKLNLSH | 66 | A6NM36 | |
| KVKSLGDHEWNRTQQ | 591 | O75334 | |
| LHVTANGSLELAKWQ | 1321 | Q6ZRI0 | |
| AQELWNKGALSLSHV | 156 | O94941 | |
| VTASEDHTLKLWNLQ | 496 | Q13033 | |
| GSNKENVHSWLILQV | 601 | Q92673 | |
| VTFINWGNLNITKIH | 566 | P07814 | |
| IQNGWKTTSHTELVR | 751 | Q9BYH1 | |
| VTKQWVEGLRSIIHN | 121 | Q15147 | |
| NTCLKSTGELVVQWH | 136 | Q8TCC3 | |
| QNLTQGWEEIKHLKS | 4126 | Q8NF91 | |
| HQIQSWQGELKLLTS | 4856 | Q8NF91 | |
| QSESADLIHWLQSAK | 6801 | Q8NF91 | |
| QSNSSKILVGRWHLA | 936 | P12259 | |
| SWLDSVVTQVLKQHA | 586 | P48378 | |
| LDLWSSVSAEAQHQK | 336 | Q5JXC2 | |
| STWHKAIAQGIQELS | 601 | Q6ZUM4 | |
| WLSLHLQDQKVVLSS | 276 | P04278 | |
| TITRKDIQTLNHLNW | 451 | Q9P0U3 | |
| LKENWLQHRGTVTET | 226 | Q92565 | |
| SLGWQLTSQETHELQ | 571 | Q7Z333 | |
| SSIFQHNVEGWKINS | 61 | Q92187 | |
| HNVEGWKINSSLVLE | 66 | Q92187 | |
| QNISRIHLVDKWNGL | 226 | Q8WTV0 | |
| LQEIKQNLHTWNSSL | 176 | Q2NL68 | |
| TTWDLISLHSNKVEN | 321 | Q9BZV3 | |
| WLHQDDKQILENLST | 241 | Q96AB6 | |
| GQASENKWSHLLVQR | 166 | Q5T5J6 | |
| HQILQQTERTSGKVW | 146 | Q96J65 | |
| LHWDENTDVITGLKQ | 491 | Q9HBY0 | |
| DLDKWLHGLESQIQS | 1391 | Q01082 | |
| WIQNTLGVNVEHKTT | 131 | O00116 | |
| KEQGWDHIQTIDSLL | 261 | Q9Y4X0 | |
| LDHNIVTAQTTWKGL | 36 | O00501 | |
| NVWLNKLGSAVIHQE | 591 | G9CGD6 | |
| THCLWTDQLLQGSEK | 166 | P01033 | |
| KNVTGILWNLSSSDH | 421 | Q9Y446 | |
| DKCVHIWNTQSGNLV | 526 | O60907 | |
| LNHTTKWLTQAAGDL | 241 | Q8WWU5 | |
| TNGCIDKLVNWIHSN | 221 | Q86UF1 | |
| AVQHVNLLKEWSNSL | 256 | Q13114 | |
| KIHTIEEFSWLQNTN | 1006 | O14709 | |
| SQGHWSNKDILRLLE | 6 | P0CB47 | |
| GLNKHSLSTQEISQW | 2296 | Q8IZQ1 | |
| STTWFQTLIHLLKGN | 46 | Q7Z2H8 | |
| SWSLDLGLQENHKVL | 446 | Q6IEE8 | |
| HISRVKSVNLDQWTQ | 61 | Q8WU79 | |
| LKQQLQWDPSSHSLQ | 286 | Q9H5L6 | |
| DSNGKAIWTAHLNIT | 31 | Q8N7C7 | |
| EKELLHSQNTWLNTE | 186 | P12270 | |
| HAQALSDSEIQLTWK | 651 | P35590 | |
| LHQGKWEVFNESLLT | 186 | Q8N4C7 | |
| ESVSSHDIWVLKQQL | 441 | Q5VZP5 | |
| LDQVWVIANKVQGSH | 1086 | Q7Z6L1 | |
| HISRVKSVNLDQWTA | 66 | Q8IYB5 | |
| LKIVLRGNHTTQDWA | 3126 | Q86WI1 | |
| IKLHDQSIGTQQWEH | 111 | O00220 | |
| KNIQDISWHTINNTI | 476 | Q8TE23 | |
| LGINFDHIWQKTLTV | 96 | Q969M3 | |
| NSKLSTQIHELEDNW | 216 | Q9H6N6 | |
| KLHVSRQNSWLGDIL | 586 | Q9H330 | |
| RVLQEQLGWNTHKET | 181 | P51815 | |
| WEEVQSKANHLLLNT | 386 | O14863 | |
| WNAVKHLTLQLEVQS | 1061 | Q7Z7G8 | |
| LQSINIGTAQWHQLK | 1631 | Q7Z7G8 | |
| QSLISSEKWLQLHGL | 31 | Q502W6 | |
| TVLLHVTGKWNSINS | 146 | Q9BXE9 | |
| SWRTQHIGNQEENKS | 956 | P08575 | |
| VNGNQSLSSQKHWLF | 1866 | P01266 | |
| DQHGLLWNLSSNDKL | 501 | Q99959 | |
| ALQTGTTEWFHLKQQ | 461 | Q70J99 | |
| GIWEHQFLVQNTTEK | 191 | P48595 | |
| LKLLHITDNNLQDWT | 176 | Q5QJ74 | |
| LGELKQNLSRSWHDV | 86 | O43399 | |
| RTLQQGVLQDWAIKH | 71 | Q96MR9 | |
| GVLQDWAIKHQTSVS | 76 | Q96MR9 | |
| WAIKHQTSVSALQQE | 81 | Q96MR9 | |
| QENWKRHLGSEASTQ | 131 | Q8TF47 | |
| ILATLHAISSKNQIW | 116 | P23378 |